- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Puma Biotechnology (NASDAQ:PBYI), Quotes and News Summary
Puma Biotechnology (NASDAQ: PBYI)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.010 | 0.1600 | ||||
| REV | 45.070M | 45.700M | 630.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Puma Biotechnology Questions & Answers
You can purchase shares of Puma Biotechnology (NASDAQ: PBYI) through any online brokerage.
Other companies in Puma Biotechnology’s space includes: CytomX Therapeutics (NASDAQ:CTMX), OncoCyte (NASDAQ:OCX), Immuneering (NASDAQ:IMRX), Fusion Pharmaceuticals (NASDAQ:FUSN) and Finch Therapeutics Group (NASDAQ:FNCH).
The latest price target for Puma Biotechnology (NASDAQ: PBYI) was reported by HC Wainwright & Co. on Friday, May 6, 2022. The analyst firm set a price target for 12.00 expecting PBYI to rise to within 12 months (a possible 321.05% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Puma Biotechnology (NASDAQ: PBYI) is $2.85 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Puma Biotechnology.
Puma Biotechnology’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Puma Biotechnology.
Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.